PACB
Pacific Biosciences·NASDAQ
--
--(--)
--
--(--)
PACB fundamentals
Pacific Biosciences (PACB) Revenue Breakdown: Q3 2025 Business & Regional Performance
Pacific Biosciences (PACB) reported total revenue of 38.44M USD in Q3 2025, with its core business segment Product contributing 84.80%. Regionally, North America remained the largest market, accounting for 47.08% of total revenue. Explore Pacific Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Pacific Biosciences (PACB) reported total revenue of 38.44M USD in Q3 2025, with its core business segment Product contributing 84.80%. Regionally, North America remained the largest market, accounting for 47.08% of total revenue. Explore Pacific Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Pacific Biosciences next quarter?What is Pacific Biosciences's gross profit margin?What is Pacific Biosciences's latest dividend and current dividend yield?What does Pacific Biosciences do and what are its main business segments?What is the revenue and EPS growth rate for Pacific Biosciences year over year?Did Pacific Biosciences beat or miss consensus estimates last quarter?What factors drove the changes in Pacific Biosciences's revenue and profit?What guidance did Pacific Biosciences's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
